|
|
- 2018
Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitusDOI: 10.1186/s12933-018-0797-6 Keywords: Empagliflozin, Metformin, Empagliflozin/metformin, Vascular protection, Arterial stiffness, Endothelial function Abstract: Patient characteristics in study groups at inclusion in the study (before) and after 12 weeks of treatment (after) with empagliflozin 25 mg daily (EMPA), metformin 2000 mg daily (MET), empagliflozin/metformin (EMPA/MET) or placebo (PLACEBO
|
